Objective. Students will classify the major psychiatric medication categories, describe their general mechanisms and common observable side effects, and explain the technician's role in reporting adverse effects within scope of practice.
This lesson, its worked examples and its practice questions has not yet been verified by a licensed clinician in the field or by a certification or approval body. It is a study draft and may contain errors. Do not use it to make decisions about any patient or medication. Always follow your instructor, your supervising professional, and current official references and regulations.
VoTechWorks program approval and accreditation are still in progress. Credentials are issued only by the certifying bodies named in each program, after their own exams.
Psychiatric technicians do not prescribe, administer, or adjust medications—those actions fall outside your scope of practice. However, you spend more direct time with patients than almost any other member of the treatment team. That means you are often the first person to notice when a medication is helping, when a side effect is developing, or when a patient is in distress. Accurate observation and timely reporting are not optional extras; they are core professional responsibilities that directly protect patient safety.
Antipsychotics are used primarily to treat symptoms of psychosis—hallucinations, delusions, disorganized thinking—and are also used in bipolar disorder and some other conditions.
Typical (first-generation) antipsychotics work mainly by blocking dopamine receptors in the brain. Examples include haloperidol and chlorpromazine. Because dopamine pathways also control movement, these agents carry a significant risk of extrapyramidal symptoms (EPS)—movement-related side effects that include muscle rigidity, tremor, restlessness (akathisia), and involuntary repetitive movements (tardive dyskinesia with long-term use).
Atypical (second-generation) antipsychotics act on both dopamine and serotonin receptors. Examples include risperidone, quetiapine, and olanzapine. They carry a lower EPS risk than typicals but are associated with metabolic side effects: weight gain, elevated blood sugar, and changes in cholesterol.
A rare but life-threatening emergency associated with antipsychotics is neuroleptic malignant syndrome (NMS)—characterized by high fever, severe muscle rigidity, altered mental status, and unstable vital signs. NMS requires immediate escalation to a nurse or physician.
Mood stabilizers are used to reduce the frequency and severity of mood episodes in conditions such as bipolar disorder. The most well-known is lithium, which has a narrow therapeutic range—meaning the difference between an effective dose and a toxic dose is small. Observable signs of lithium toxicity include coarse hand tremor, confusion, slurred speech, nausea, and in severe cases seizures. Any suspected lithium toxicity requires immediate reporting.
Anticonvulsant medications such as valproate and lamotrigine are also used as mood stabilizers. Common side effects include sedation, dizziness, and GI upset. Patients on these medications may have regular lab work ordered to monitor drug levels and organ function; technicians support this process by observing for side effects and ensuring patients keep appointments.
Antidepressants treat major depressive disorder, anxiety disorders, and several other conditions. The most commonly prescribed group is selective serotonin reuptake inhibitors (SSRIs), which increase the availability of serotonin in the brain. Common side effects include nausea, sleep changes, and sexual dysfunction.
Serotonin syndrome is a dangerous condition that can occur when serotonin activity becomes excessive—often when multiple serotonergic agents are combined. Signs include agitation, rapid heart rate, elevated temperature, and muscle twitching. This is a medical emergency requiring immediate escalation.
A critical safety point: antidepressants carry a black-box warning for increased suicidal thinking in some populations, particularly early in treatment. Technicians must monitor for any expression of suicidal ideation and report it immediately according to facility policy.
This class includes benzodiazepines (such as lorazepam and diazepam), which enhance the effect of GABA—an inhibitory neurotransmitter—to reduce anxiety and promote sedation. They are effective but carry risks of physical dependence and cognitive effects. Technicians should observe for over-sedation, unsteady gait (fall risk), and respiratory depression. Abrupt discontinuation of benzodiazepines can cause life-threatening withdrawal, so technicians must report if a patient refuses or is unable to take scheduled doses.
Non-benzodiazepine agents (such as buspirone) are also used for anxiety with different side-effect profiles.
Stimulants such as amphetamine-based medications are prescribed for attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. They increase dopamine and norepinephrine activity. Technicians should monitor for decreased appetite, elevated heart rate, elevated blood pressure, insomnia, and signs of agitation or anxiety. Because stimulants have abuse potential, facilities have specific handling and documentation procedures for them.
Your pharmacology role can be summarized in three words: observe, document, report.
When a patient refuses oral medication, your role is to listen respectfully, document the refusal accurately (including exact words when relevant), and notify the nurse promptly. You do not coerce the patient or attempt to re-administer.
State licensure laws and facility policies define your scope precisely. In all four states that license psychiatric technicians (California, Colorado, Kansas, and Arkansas), and in settings where technicians hold only the AMCA Mental Health Technician Certification, medication administration requires a separate, explicit authorization. When in doubt, ask your supervisor before acting.
Answer each question, then check it. Nothing is recorded; this is your own practice.
A free tech program — complimentary, as our commitment to get America working. Help us build VoTechWorks. Tell us what works, what doesn’t, and what you want to learn.